Literature DB >> 12583457

Economic evaluation of vaccination programs: the impact of herd-immunity.

M Brisson1, W J Edmunds.   

Abstract

The unique characteristic of vaccination is that it not only reduces the incidence of disease in those immunized but also indirectly protects nonvaccinated susceptibles against infection (produces herd-immunity). The bulk of economic evaluations of vaccination programs continue to use models that cannot take into account the indirect effects produced by herd-immunity. Here, the authors illustrate the importance of incorporating herd-immunity externalities when assessing the cost-effectiveness of vaccination progams. To do this, they compare 2 methods of estimating the benefits of routine mass vaccination: one that includes herd-immunity (dynamic approach) and one that does not (static approach). Finally, they use the results to clarify a number of misconceptions that are common in the literature concerning herd-immunity and dynamical effects produced by models.

Entities:  

Mesh:

Year:  2003        PMID: 12583457     DOI: 10.1177/0272989X02239651

Source DB:  PubMed          Journal:  Med Decis Making        ISSN: 0272-989X            Impact factor:   2.583


  71 in total

1.  A decision chart for assessing and improving the transferability of economic evaluation results between countries.

Authors:  Robert Welte; Talitha Feenstra; Hans Jager; Reiner Leidl
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

Review 2.  Rotavirus vaccine RIX4414 (Rotarix™): a pharmacoeconomic review of its use in the prevention of rotavirus gastroenteritis in developing countries.

Authors:  Greg L Plosker
Journal:  Pharmacoeconomics       Date:  2011-11       Impact factor: 4.981

3.  Routine immunization of adults in Canada: Review of the epidemiology of vaccine-preventable diseases and current recommendations for primary prevention.

Authors:  Michael D Parkins; Shelly A McNeil; Kevin B Laupland
Journal:  Can J Infect Dis Med Microbiol       Date:  2009       Impact factor: 2.471

4.  A generic simulation model to manage a vaccination program.

Authors:  Arben Asllani; Lawrence Ettkin
Journal:  J Med Syst       Date:  2010-01-29       Impact factor: 4.460

Review 5.  The role of economic evaluation in vaccine decision making: focus on meningococcal group C conjugate vaccine.

Authors:  Robert Welte; Caroline L Trotter; W John Edmunds; Maarten J Postma; Philippe Beutels
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

6.  Imitation dynamics predict vaccinating behaviour.

Authors:  Chris T Bauch
Journal:  Proc Biol Sci       Date:  2005-08-22       Impact factor: 5.349

7.  Dynamic modelling of infectious diseases: an application to the economic evaluation of influenza vaccination.

Authors:  Roberto Pradas-Velasco; Fernando Antoñanzas-Villar; María Puy Martínez-Zárate
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

Review 8.  Cost-effectiveness analyses of vaccination programmes : a focused review of modelling approaches.

Authors:  Sun-Young Kim; Sue J Goldie
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

9.  Synthesizing epidemiological and economic optima for control of immunizing infections.

Authors:  Petra Klepac; Ramanan Laxminarayan; Bryan T Grenfell
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-08       Impact factor: 11.205

10.  A cost-utility analysis of cervical cancer vaccination in preadolescent Canadian females.

Authors:  Andrea M Anonychuk; Chris T Bauch; Maraki Fikre Merid; Georges Van Kriekinge; Nadia Demarteau
Journal:  BMC Public Health       Date:  2009-10-31       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.